- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Jagsonpal Pharmaceuticals Ltd is primarily engaged in the manufacturing and trading of pharmaceutical products and APIs. It has operations in India and caters to both domestic and international markets.
Jagsonpal Pharma delivered robust Q1 FY27 financial results: revenue grew 9% to Rs. 82 Cr, EBITDA rose 21% to Rs. 19 Cr, and PAT increased 22% to Rs. 13 Cr. Gross margins surpassed 65%. A key strategic move was acquiring an 85% stake in Aequitas Healthcare for Rs. 20.8 Cr,...